In the research chemical market, there are a lot of grifters who are not spending money on the things they should be doing when they manufacture. According to the NIH, BPC-157 demonstrates therapeutic potential across a broad range of musculoskeletal injuries through its angiogenic, anti-inflammatory, cytoprotective and tissue-regenerative properties However, despite this promise, and growing interest in athletic and online communities, human data is exceedingly sparse. As of August 2025, only three pilot studies had been conducted on the human use of BPC-157
Quite bizarre when these patients wouldnt be deficient in the first place if they could absorb B12 from food
it does not carry the multi-year post-marketing safety record of an approved drug
So the chemically castrated patient, meaning they have no testosterone so if you treat a patient who has no testosterone and you take them from zero testosterone to normal testosterone, so to take them from, let's say, zero to 350, um, during that climb from zero to 350, you can increase theoretically, the risk of exasperating a prostate cancer that's pre pre-existing was the fear
It is also easy to see immediately whether a point is another point rotated by some multiple of 60
